floxuridine [Ligand Id: 4801] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL917 (5-Fluoro-2-deoxyuridine, 5-fudr, Floxuridine, Fluoruridine deoxyribose, F.u.d.r., Fudr, FUDR, NSC-27640)
  • thymidylate synthetase/Thymidylate synthase in Mouse [ChEMBL: CHEMBL3160] [GtoPdb: 2642] [UniProtKB: P07607]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
thymidylate synthetase/Thymidylate synthase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3160] [GtoPdb: 2642] [UniProtKB: P07607]
ChEMBL Inhibition of cellular thymidylate synthase activity of murine leukemia cell line (L1210) in permeabilised cells. B 4.23 pIC50 59000 nM IC50 J Med Chem (1996) 39: 4569-4575 [PMID:8917645]
ChEMBL Inhibition of cellular thymidylate synthase activity of mouse fibroblast (L929 TK-) in permeabilised cells. B 4.96 pIC50 11000 nM IC50 J Med Chem (1996) 39: 4569-4575 [PMID:8917645]
ChEMBL Inhibition of cellular thymidylate synthase activity of mouse fibroblast (L929 TK-) in intact cells. B 5.14 pIC50 7300 nM IC50 J Med Chem (1996) 39: 4569-4575 [PMID:8917645]
ChEMBL Thymidylate synthase inhibition in thymidine kinase deficient LM cells after 2 hr treatment B 5.27 pIC50 5400 nM IC50 J Med Chem (2001) 44: 4475-4480 [PMID:11728193]
ChEMBL Thymidylate synthase inhibition in wild type LM cells after 2 hr treatment B 6.59 pIC50 260 nM IC50 J Med Chem (2001) 44: 4475-4480 [PMID:11728193]
ChEMBL Inhibition of cellular thymidylate synthase activity of murine leukemia cell line (L1210) in intact cells. B 7.37 pIC50 43 nM IC50 J Med Chem (1996) 39: 4569-4575 [PMID:8917645]
ChEMBL Thymidylate synthase inhibition in thymidine kinase deficient /TK cells after 2 hr treatment B 7.7 pIC50 20 nM IC50 J Med Chem (2001) 44: 4475-4480 [PMID:11728193]
ChEMBL Thymidylate synthase inhibition in L1210 mouse leukemia cells after 2 hr treatment B 8.1 pIC50 7.9 nM IC50 J Med Chem (2001) 44: 4475-4480 [PMID:11728193]
ChEMBL Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 4 hrs by liquid scintillation counting B 9.15 pIC50 0.7 nM IC50 Eur J Med Chem (2011) 46: 993-1005 [PMID:21330014]
ChEMBL Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 24 hrs by liquid scintillation counting B 9.15 pIC50 0.7 nM IC50 Eur J Med Chem (2011) 46: 993-1005 [PMID:21330014]
ChEMBL Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 15 mins by liquid scintillation counting B 9.22 pIC50 0.6 nM IC50 Eur J Med Chem (2011) 46: 993-1005 [PMID:21330014]
ChEMBL Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 15 mins by liquid scintillation counting B 9.22 pIC50 0.6 nM IC50 Eur J Med Chem (2011) 46: 993-1005 [PMID:21330014]
ChEMBL Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 24 hrs by liquid scintillation counting B 9.4 pIC50 0.4 nM IC50 Eur J Med Chem (2011) 46: 993-1005 [PMID:21330014]
ChEMBL Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 4 hrs by liquid scintillation counting B 9.4 pIC50 0.4 nM IC50 Eur J Med Chem (2011) 46: 993-1005 [PMID:21330014]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]